Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DCPLA-ME (2-[(2-Pentylcyclopropyl)methyl]cyclopropaneoctanoic acid methyl ester) is the methyl ester form of DCPLA and can be used to treat neurodegenerative diseases. It is an effective PKCε activator.
説明 | DCPLA-ME (2-[(2-Pentylcyclopropyl)methyl]cyclopropaneoctanoic acid methyl ester) is the methyl ester form of DCPLA and can be used to treat neurodegenerative diseases. It is an effective PKCε activator. |
別名 | Methyl 8-[2-[(2-pentylcyclopropyl)methyl]cyclopropyl]octanoate, 2-[(2-Pentylcyclopropyl)methyl]cyclopropaneoctanoic acid methyl ester, Methyl 8-(2-((2-pentylcyclopropyl)methyl)cyclopropyl)octanoate, DCPLA methyl ester |
分子量 | 322.53 |
分子式 | C21H38O2 |
CAS No. | 56687-67-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 1mg/ml, Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DCPLA-ME 56687-67-3 Chromatin/Epigenetic Cytoskeletal Signaling PKC Methyl 8-[2-[(2-pentylcyclopropyl)methyl]cyclopropyl]octanoate 2-[(2-Pentylcyclopropyl)methyl]cyclopropaneoctanoic acid methyl ester Methyl 8-(2-((2-pentylcyclopropyl)methyl)cyclopropyl)octanoate DCPLA methyl ester Inhibitor inhibitor inhibit